I'm pleased to bring you a detailed summary of our expanding intra- and extramural programs in our Research Report for 2011, along with upcoming milestones and goals for the year ahead.
It's with great pleasure that I announce the release of our Annual Report for 2011. The report includes updates on all of our research projects, both at the Research Center in Mountain View, and at leading universities and institutions around the world. It reviews the success of SENS 5 and the expansion of our Academic Initiative, and summarises our financial situation through 2011.
An archived copy of SENS Research Foundation's 2011 Holiday Appeal newsletter.
On 19 September, 2011, Sarah Marr will be stepping down as our Executive Vice President at SENS Foundation. She has been a committed co-founder, and she will of course continue to be a trusted advisor and closely involved with the organization. But we couldn't have her term of full-time service with us pass without noting the significant contribution she has made to the professionalism of the organization and to the quality of our overall message.
SENS Foundation's Year End Report for 2010, including an overview of the year from our CEO, Mike Kope; a research summary from CSO Aubrey de Grey; commentaries on our Research Center operations and our outreach activities; and a breakdown of our 2010 finances.
SENS Foundation is pleased to announce that it has been granted tax-exempt status as a 501(c)(3) public charity, with an effective date of March 9, 2009. Donations to the Foundation are fully deductible as a charitable contribution.
The global scientific community is increasingly recognizing the role of rejuvenation biotechnologies in addressing age-related disease. This week, Arizona-based businessman Jason Hope announced a $500,000 donation to SENS Foundation, a California-based non-profit organization that works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.
Last night, Peter Thiel hosted "Breakthrough Philanthropy", a dinner and presentation event showcasing eight non-profit organizations focused upon game-changing approaches to their fields. It was a wonderful opportunity for us to convey our message to a large group of entrepreneurs and philanthropists interested in the genuinely transformative. Our thanks to the Thiel Foundation, and the Seasteading Institute, for their efforts in creating that event.
Over the last few days we’ve been working to change some of the content of our website, and this seems like a good time to contextualize those changes in a broader discussion of SENS Foundation: who we are, what we want to achieve, why we want to achieve it, and some things we need to do in order to get there. I’ll also address some of the misconceptions about us which I think exist.
This October, Hannover and Detroit will host two of the year's most interesting and wide-ranging scientific conferences in the biomedical field. I'll be chairing sessions at both events, focused on the application of regenerative medicine to aging and aging-related disease - a synergy we at SENS Foundation term rejuvenation biotechnology.
On behalf of SENS Foundation, I'm pleased to announce the launch of a competitive research prize for "Breaking Advanced Glycation Endproduct Glucosepane, a Protein Cross-link" through Innocentive, a global leader in open innovation. This $20,000 Theoretical Research prize is designed to give us a clear enough roadmap towards the breakage of glucosepane that we can attract the further financial and scientific resources needed for a full-scale research and development project.